                         SEQUENCE LISTING

<110>  Singapore Health Services Pte Ltd
 
<120>  Method of modulating sensitivity to tyrosine kinase inhibitor

<130>  72760PCT

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  pLKO.1-shIsoD_A

<400>  1
ttgctgagtg aatgaacaaa t                                                 21


<210>  2
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  pLKO.1-shIsoD_B

<400>  2
agccagctgt gggacaatta t                                                 21


<210>  3
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  pLKO.1-shIsoD_C

<400>  3
gccagccttc tccgtaatta g                                                 21


<210>  4
<211>  34
<212>  DNA
<213>  Artificial sequence

<220>
<223>  EGFR isoform D open reading frame cloning primer 1, for cloning 
       into modified pCSC-SP-PW

<400>  4
ggatccattg gctagcatgc gaccctccgg gacg                                   34


<210>  5
<211>  35
<212>  DNA
<213>  Artificial sequence

<220>
<223>  EGFR isoform D open reading frame cloning primer 2, for cloning 
       into modified pCSC-SP-PW

<400>  5
cctgcagctg ctcgagtcag tggcaggagg aggcc                                  35


<210>  6
<211>  35
<212>  DNA
<213>  Artificial sequence

<220>
<223>  EGFR isoform D open reading frame cloning primer 1, for cloning 
       into pet15b

<400>  6
cgcgcggcag ccatatgatg cgaccctccg ggacg                                  35


<210>  7
<211>  35
<212>  DNA
<213>  Artificial sequence

<220>
<223>  EGFR isoform D open reading frame cloning primer 2, for cloning 
       into pet15b

<400>  7
cagccggatc ctcgagtcag tggcaggagg aggcc                                  35


